Stay updated with breaking news from Casi blade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright boosted their target price on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy […] ....
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report published on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright lifted their price objective on CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy rating in a research report on […] ....
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright raised their price objective on CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy rating in a […] ....
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright boosted their price objective on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy rating in a […] ....
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright raised their price objective on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy rating in a […] ....